Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume 87, Issue 3, Pages 284-293
Publisher
Wiley
Online
2012-02-13
DOI
10.1002/ajh.23135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Infrequent occurrence of MPL exon 10 mutations in polycythemia vera and post-polycythemia vera myelofibrosis
- (2011) Animesh Pardanani et al. AMERICAN JOURNAL OF HEMATOLOGY
- The JAK2 exon 12 mutations: A comprehensive review
- (2011) Linda M. Scott AMERICAN JOURNAL OF HEMATOLOGY
- Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations
- (2011) F. Passamonti et al. BLOOD
- Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
- (2011) A. Carobbio et al. BLOOD
- Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis
- (2011) Animesh Pardanani et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Polycythemia Vera With Hydroxyurea and Pipobroman: Final Results of a Randomized Trial Initiated in 1980
- (2011) Jean-Jacques Kiladjian et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patients
- (2011) A Pardanani et al. LEUKEMIA
- Polycythemia vera-associated acquired von Willebrand syndrome despite near-normal platelet count
- (2010) Ayalew Tefferi et al. AMERICAN JOURNAL OF HEMATOLOGY
- A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs
- (2010) Elena Crisà et al. ANNALS OF HEMATOLOGY
- Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia
- (2010) A. Alvarez-Larran et al. BLOOD
- Clinical utility of routineMPLexon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis
- (2010) Elaine M. Boyd et al. BRITISH JOURNAL OF HAEMATOLOGY
- A prospective study of haemostatic parameters in relation to the clinical course of myeloproliferative disorders
- (2010) A. Wehmeier et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations
- (2010) A Pardanani et al. LEUKEMIA
- Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
- (2010) A Tefferi LEUKEMIA
- A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications
- (2010) F Passamonti et al. LEUKEMIA
- Essential thrombocythemia and pregnancy: Observations from recent studies and management recommendations
- (2009) Ayalew Tefferi et al. AMERICAN JOURNAL OF HEMATOLOGY
- The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)
- (2009) E. Voskaridou et al. BLOOD
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Different lineage involvement in myelodysplastic/myeloproliferative disease with combinedMPLW515LandJAK2V617Fmutation
- (2009) Kais Hussein et al. BRITISH JOURNAL OF HAEMATOLOGY
- Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies
- (2009) Naseema Gangat et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia
- (2009) K. Liu et al. HAEMATOLOGICA
- Two rare MPL gene mutations in patients with essential thrombocythemia
- (2009) Haruhiko Ohashi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Bone Marrow Fibrosis and Diagnosis of Essential Thrombocythemia
- (2009) Juergen Thiele et al. JOURNAL OF CLINICAL ONCOLOGY
- Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera
- (2009) Alfonso Quintás-Cardama et al. JOURNAL OF CLINICAL ONCOLOGY
- Aspirin in pregnant patients with essential thrombocythemia: a retrospective analysis of 129 pregnancies
- (2009) F. PASSAMONTI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- MPLW515L mutation in acute megakaryoblastic leukaemia
- (2009) K Hussein et al. LEUKEMIA
- Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia
- (2008) A. M. Vannucchi et al. BLOOD
- Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
- (2008) J.-J. Kiladjian et al. BLOOD
- MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort
- (2008) P. A. Beer et al. BLOOD
- JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis
- (2008) A. H. Schmitt-Graeff et al. HAEMATOLOGICA
- Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients
- (2008) F. Passamonti et al. HAEMATOLOGICA
- The Role of Clopidogrel and Acetylsalicylic Acid in the Prevention of Early-Phase Graft Occlusion Due to Reactive Thrombocytosis after Coronary Artery Bypass Operation
- (2008) Ilyas Kayacioglu et al. HEART SURGERY FORUM
- Evidence and expertise in the management of polycythemia vera and essential thrombocythemia
- (2008) G Finazzi et al. LEUKEMIA
- Interferon-α therapy in bcr-abl-negative myeloproliferative neoplasms
- (2008) J-J Kiladjian et al. LEUKEMIA
- Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal
- (2008) A M Vannucchi et al. LEUKEMIA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now